A difference in effectiveness between infliximab, etanercept and adalimumab in patients with rheumatoid arthritis.

被引：0
|
作者：
Kievit, Wietske
Fransen, Jaap
Kuper, Ina H.
van de Laar, Mart A. F. J.
Jansen, Tim L.
De Rooij, Dirk jan R. A. M.
de Gendt, Carla M.
Ronday, Karel H.
Brus, Herman L. M.
van Ooijen, Piet C. M.
van Riel, Piet C. L. M.
机构：
[1] Radboud Univ Nijmegen Med Ctr, Nijmegen, Netherlands
[2] Med Spectrum Twente, Enschede, Netherlands
[3] Med Ctr Leeuwarden, Leeuwarden, Netherlands
[4] Sint Maartensklin, Nijmegen, Netherlands
[5] Ziekenhuis Rijnstate, Arnhem, Netherlands
[6] Zienkenhuis Leyenburg, The Hague, Netherlands
[7] Twee Steden Ziekenhuis, Tilburg, Netherlands
[8] Jeroen Bosch Ziekenhuis, Den Bosch, Netherlands
来源：
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S309 / S310
页数：2
相关论文
共 50 条
  • [1] Compare effectiveness and safety over five years of infliximab, etanercept and adalimumab in a cohort of patients with rheumatoid arthritis.
    López-Lasanta, María A.
    Ureña, Inmaculada
    Sánchez-Fernández, Simón A.
    Díaz-Cordovés, Gisela
    Jiménez-Núñez, Francisco G.
    Irigoyen, María V.
    Belmonte, María A.
    Coret, Virginia
    Rodríguez-Pérez, Manuel
    Calero, Enrique
    Ponce, Antonio
    Fernández-Nebro, Antonio
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S416 - S416
  • [2] Drug-survival, effectiveness and safety of infliximab, adalimumab and etanercept in rheumatoid arthritis patients
    Flendrie, M.
    Creemers, M. C. W.
    Welsing, P. M. J.
    Van den Hoogen, F. H. J.
    Van Riel, P. L. C. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 191 - 191
  • [3] The efficacy of switching from etanercept to infliximab in patients with rheumatoid arthritis.
    Hansen, KE
    Cush, JJ
    Patel, S
    Genovese, MC
    Schiff, M
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S538 - S538
  • [4] Infliximab, Etanercept, and Adalimumab switching in patients with rheumatoid arthritis in the CORRONA database
    Dabbous, O.
    Kremer, J.
    Rambharose, J.
    El Taha, M.
    Reed, G.
    Tang, B.
    Thomson, H.
    Domdey, A.
    Rahman, M.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2008, 37 : 42 - 42
  • [5] Effectiveness of dose reduction of etanercept and adalimumab in patients with rheumatoid arthritis
    Rosalía Martínez-Pérez
    Sergio Rodríguez-Montero
    Alejandro Muñoz
    Julia Uceda
    Mario León
    Francisco Gallo
    Maria Luisa Velloso
    José Luis Marenco
    Journal of Translational Medicine, 9 (Suppl 2)
  • [6] Efficiency of adalimumab, etanercept and infliximab in rheumatoid arthritis patients: dosing patterns and effectiveness in daily clinical practice
    Ramirez-Herraiz, E.
    Escudero-Vilaplana, V.
    Alanon-Plaza, E.
    Trovato-Lopez, N.
    Herranz-Alonso, A.
    Morell-Baladron, A.
    Sanjurjo-Saez, M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2013, 31 (04) : 559 - 565
  • [7] Cost-Effectiveness Analysis of Biopharmaceuticals for Treating Rheumatoid Arthritis: Infliximab, Adalimumab, and Etanercept
    Gholami, Ahmad
    Azizpoor, Jassem
    Aflaki, Elham
    Rezaee, Mehdi
    Keshavarz, Khosro
    BIOMED RESEARCH INTERNATIONAL, 2021, 2021
  • [8] Cost effectiveness of infliximab in rheumatoid arthritis.
    Kavanaugh, A
    Patel, KK
    Bala, M
    Noe, L
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S144 - S144
  • [9] Dosing patterns and costs of adalimumab, etanercept, and infliximab among patients with rheumatoid arthritis
    Engel-Nitz, N. M.
    Huang, X.
    Globe, D.
    Baumgartner, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 260 - 260
  • [10] COMPARISON OF HEALTHCARE COSTS BETWEEN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH INFLIXIMAB, ETANERCEPT AND ADALIMUMAB IN NORDIC SETTING
    Gokhale, S. B.
    Cassel, T.
    Mahon, R.
    Balkin, P. E.
    Singh, S.
    Bhattacharyya, S.
    Handin, J.
    Mendoza, C.
    VALUE IN HEALTH, 2016, 19 (07) : A535 - A535
12345